In our study, the association of CR1 polymorphism with lung cancer is biologically plausible in that the intronic polymorphism could affect the density of CR1 molecules on the cell surface, thereby contributing to autoimmune disorders and neoplasm. Here, CR1 is linked to lung cancer.